Who Should Get Screened for Lung Cancer?

Lung cancer screening can save lives, but many people who qualify still do not realize they are eligible. Screening is designed to find lung cancer early, before symptoms appear and while treatment may be more effective. The U.S. Preventive Services Task Force recommends annual screening with low-dose computed tomography, also called LDCT, for adults ages 50 to 80 who have a 20 pack-year smoking history and either currently smoke or quit within the past 15 years.

What Is a Pack-Year?

A pack-year is a way to measure smoking exposure over time. One pack-year means smoking an average of one pack of cigarettes per day for one year. For example, someone who smoked one pack a day for 20 years has a 20 pack-year history. Someone who smoked two packs a day for 10 years also has a 20 pack-year history.

This matters because smoking history is one of the biggest factors used to determine screening eligibility. The USPSTF identifies smoking and older age as the two most important risk factors for lung cancer.

Who Qualifies for Screening?

A patient may qualify for annual screening if all of the following apply:

• Age 50 to 80
• At least a 20 pack-year smoking history
• Currently smokes, or quit within the last 15 years

Screening should stop once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to undergo lung surgery.

Why Early Detection Matters

One of the biggest challenges with lung cancer is that it may not cause symptoms in its earliest stages. By the time signs such as chronic cough, coughing up blood, chest pain, unexplained weight loss, or shortness of breath appear, the disease may be more advanced. Screening aims to detect cancer earlier, when treatment options may be broader.

Low-dose CT is different from a regular chest X-ray. It uses a low dose of radiation and is specifically recommended for screening in high-risk adults. The USPSTF recommends LDCT, not routine chest X-rays, for this purpose.

Screening Is Not for Everyone

Lung cancer screening is not recommended for all adults. It is meant for people at higher risk based on age and smoking history. That is why it is important to review your personal history with a physician rather than assume you do or do not qualify.

This is also a great topic for patient education because many former smokers do not realize that quitting years ago does not immediately eliminate the need for screening. Patients who quit within the past 15 years may still qualify.

A Good Conversation to Have With Your Doctor

If you are unsure whether you meet the criteria, talk with your provider. A quick review of age, years smoked, amount smoked, and quit date can help determine whether screening makes sense. For some patients, that conversation may also lead to follow-up testing, smoking cessation support, or closer pulmonary evaluation.

For Pulmonary and Medicine Associates, lung cancer screening content can be both educational and action-oriented. It helps patients understand eligibility while encouraging earlier conversations that may lead to timely diagnosis.

Do Not Wait for Symptoms

Screening is meant for people without symptoms. If you already have concerning symptoms such as ongoing cough, blood in mucus, unexplained weight loss, or persistent breathing changes, you should seek medical evaluation rather than rely only on screening.

For eligible patients, annual low-dose CT can be an important step in protecting lung health through early detection.

The post Who Should Get Screened for Lung Cancer? appeared first on Pulmonary And Medicine Associates.

Understanding Pulmonary Medicine

Pulmonary medicine focuses on the prevention, diagnosis, and treatment of diseases affecting the lungs and respiratory system. From common conditions like asthma and COPD to more complex disorders such as pulmonary fibrosis and sleep-related breathing issues, this specialty plays a vital role in helping patients breathe easier and live healthier lives.

Key Advances in Pulmonary Medicine

Over the past few years, innovations have reshaped how we diagnose and manage respiratory conditions:

1. Advanced Imaging & Diagnostics
   • High-resolution CT scans and endobronchial ultrasound allow physicians to pinpoint airway and lung abnormalities earlier.
   • Biomarkers, like fractional exhaled nitric oxide (FeNO), now help detect airway inflammation with greater accuracy, especially in asthma patients.
2. Targeted & Personalized Therapies
   • Biologic medications have revolutionized asthma and COPD care, targeting the underlying pathways of inflammation rather than just symptoms.
   • Personalized treatment plans, based on patient genetics and lung function, are becoming standard practice.
3. Sleep Medicine Integration
   • Sleep disorders such as obstructive sleep apnea are increasingly recognized as risk factors for heart disease, diabetes, and stroke.
   • Advances in CPAP and non-invasive ventilation therapies are making treatment more effective and comfortable.
4. Post-COVID Lung Health
   • Pulmonary rehabilitation programs are essential for patients recovering from long COVID and persistent breathing difficulties.
   • New research is helping doctors better understand long-term lung scarring and how to prevent it.

Why Early Diagnosis Matters

Early detection of respiratory conditions can make all the difference. For example:

• Catching COPD in its early stages can slow progression and improve quality of life.
• Identifying airway inflammation early through FeNO testing can help physicians adjust treatment before symptoms worsen.

How Pulmonary & Medicine Associates Supports Patients

At PMA, our expert providers offer:

• Comprehensive diagnostic testing for asthma, COPD, and sleep disorders.
• Personalized treatment plans tailored to each patient’s needs.
• Long-term support and monitoring to ensure better outcomes.

Our commitment is simple: helping patients breathe easier, recover faster, and live healthier lives.

The post Advances in Pulmonary Medicine: Improving Lung Health for a Better Future appeared first on Pulmonary And Medicine Associates.

Lung cancer remains the leading cause of cancer-related death in the United States, but early detection saves lives. Thanks to low-dose CT (LDCT) screening, doctors can now find lung cancer at earlier, more treatable stages. However, not everyone needs this screening—guidelines help identify who will benefit most.

According to the U.S. Preventive Services Task Force (USPSTF), adults should consider annual lung cancer screening if they meet these criteria:

✅ Aged 50 to 80 years
✅ Have a 20-pack-year smoking history (for example, smoking one pack a day for 20 years)
✅ Currently smoke or have quit within the past 15 years

Low-dose CT scans are painless and take only a few minutes. Unlike standard chest X-rays, LDCT is much better at detecting small lung nodules before they cause symptoms. In large studies, this screening has been shown to reduce lung cancer deaths by up to 20%.

If you qualify, yearly screening can become part of your preventive care plan. It’s important to talk with your doctor about the risks and benefits. While LDCT can detect cancer early, it may also find nodules that are not cancerous, leading to additional tests or procedures.

For people who do not meet the screening criteria, routine screening is generally not recommended. However, any persistent cough, unexplained weight loss, or shortness of breath should always be evaluated right away.

At Pulmonary & Medicine Associates, we help you understand your lung cancer risk and whether screening is right for you. If you’re eligible, we’ll guide you through each step—from scheduling your scan to follow-up care—so you feel informed and supported.

Don’t wait for symptoms to appear. Early detection could save your life.

The post Lung Cancer Screening Guidelines: Are You Eligible? appeared first on Pulmonary And Medicine Associates.